Advertisement

Index by author

November 01, 2014; Volume 351,Issue 2

  1. O'sullivan, Saoirse Elizabeth

    1. Cannabidiol Improves Vasorelaxation in Zucker Diabetic Fatty Rats through Cyclooxygenase Activation
      Amanda J. Wheal, Mariateresa Cipriano, Christopher J. Fowler, Michael D. Randall and Saoirse Elizabeth O’Sullivan
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 457-466; DOI: https://doi.org/10.1124/jpet.114.217125

  2. Olson, Stephen

    1. Mechanisms Underlying Benign and Reversible Unconjugated Hyperbilirubinemia Observed with Faldaprevir Administration in Hepatitis C Virus Patients
      Rucha S. Sane, Gerhard G. Steinmann, Qihong Huang, Yongmei Li, Lalitha Podila, Kirsten Mease, Stephen Olson, Mitchell E. Taub, Jerry O. Stern, Gerhard Nehmiz, Wulf O. Böcher, Tarik Asselah and Donald Tweedie
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 403-412; DOI: https://doi.org/10.1124/jpet.114.218081

  3. Opacich, Jonathan W.

    1. Differential Effects of Complement Activation Products C3a and C5a on Cardiovascular Function in Hypertensive Pregnant Rats
      Kathryn E. Lillegard, Alex C. Loeks-Johnson, Jonathan W. Opacich, Jenna M. Peterson, Ashley J. Bauer, Barbara J. Elmquist, Ronald R. Regal, Jeffrey S. Gilbert and Jean F. Regal
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 344-351; DOI: https://doi.org/10.1124/jpet.114.218123

  4. Opipari, Anthony W.

    1. Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease
      Gary D. Glick, Rodrigue Rossignol, Costas A. Lyssiotis, Daniel Wahl, Charles Lesch, Brian Sanchez, Xikui Liu, Ling-Yang Hao, Clarke Taylor, Alexander Hurd, James L. M. Ferrara, Victor Tkachev, Craig A. Byersdorfer, Laszlo Boros and Anthony W. Opipari
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 298-307; DOI: https://doi.org/10.1124/jpet.114.218099

  5. Overshiner, C.

    1. M1 and M2 Muscarinic Receptor Subtypes Regulate Antidepressant-Like Effects of the Rapidly Acting Antidepressant Scopolamine
      J. M. Witkin, C. Overshiner, X. Li, J. T. Catlow, G. N. Wishart, D. A. Schober, B. A. Heinz, A. Nikolayev, V. V. Tolstikov, W. H. Anderson, R. E. Higgs, M.-S. Kuo and C. C. Felder
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 448-456; DOI: https://doi.org/10.1124/jpet.114.216804
Back to top

In this issue

Advertisement